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Abstract
Background: Imbalance of iron homeostasis has been reported in sporadic Creutzfeldt-Jakob-disease (sCJD) affected
human and scrapie infected animal brains, but the contribution of this phenotype to disease associated neurotoxicity is
unclear.
Methodology/Principal Findings: Using cell models of familial prion disorders, we demonstrate that exposure of cells
expressing normal prion protein (PrP
C) or mutant PrP forms to a source of redox-iron induces aggregation of PrP
C and
specific mutant PrP forms. Initially this response is cytoprotective, but becomes increasingly toxic with time due to
accumulation of PrP-ferritin aggregates. Mutant PrP forms that do not aggregate are not cytoprotective, and cells show
signs of acute toxicity. Intracellular PrP-ferritin aggregates induce the expression of LC3-II, indicating stimulation of
autophagy in these cells. Similar observations are noted in sCJD and scrapie infected hamster brains, lending credence to
these results. Furthermore, phagocytosis of PrP-ferritin aggregates by astrocytes is cytoprotective, while culture in astrocyte
conditioned medium (CM) shows no measurable effect. Exposure to H2O2, on the other hand, does not cause aggregation
of PrP, and cells show acute toxicity that is alleviated by CM.
Conclusions/Significance: These observations suggest that aggregation of PrP in response to redox-iron is cytoprotective.
However, subsequent co-aggregation of PrP with ferritin induces intracellular toxicity unless the aggregates are degraded
by autophagosomes or phagocytosed by adjacent scavenger cells. H2O2, on the other hand, does not cause aggregation of
PrP, and induces toxicity through extra-cellular free radicals. Together with previous observations demonstrating imbalance
of iron homeostasis in prion disease affected brains, these observations provide insight into the mechanism of neurotoxicity
by redox-iron, and the role of PrP in this process.
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Introduction
Prion disorders are a group of neurodegenerative conditions of
humans and animals that are sporadic, inherited, and infectious in
nature. The main pathogenic event in all prion disorders is change in
conformation of a normal cell surface glycoprotein, the prion protein
(PrP
C), to a b-sheet rich isoform referred to as PrP-scrapie (PrP
Sc)[ 1 ] .
Most human prion disorders are sporadic in nature, and are initiated
by conversion of PrP
C to PrP
Sc by a stochastic event. Sporadic
Creutzfeldt-Jakob disease (sCJD) is a typical example [2–4]. Inherited
forms comprise 10–15% of all cases, and are associated with point
mutations in the prion protein gene (PRNP) [5]. Infectious disorders
are relatively rare, and are acquir e dw h e na ne x o g e n o u ss o u r c eo f
PrP
Sc induces a change in conformation of host PrP
C to PrP
Sc as in
variant CJD of humans,scrapie of sheep, and chronic wasting disease
of the deer and elk population [6–8]. For all prion disorders,
manifestation of disease requires the expression of host PrP
C on
neuronal plasma membrane, where it provides the necessary
substrate for PrP
Sc and facilitates transmission of the neurotoxic
signal [9,10]. Although our understanding of events underlying the
conversion of PrP
C to PrP
Sc and mechanism(s) of neurotoxicity by
PrP
Sc has improved significantly over the past years, specific nature of
the toxic signal and the role of PrP
C in transmitting this signal are still
unclear.
Several mechanisms of toxicity by PrP
Sc have been suggested.
Principal among these are loss of normal function of PrP
C due to
aggregation, and gain of toxic function by PrP
Sc that requires
plasma membrane expression of PrP
C to be effective [11,12].
Among triggers that induce aggregation of PrP
C, redox-active
metals such as copper and iron are of particular interest since PrP
C
is involved in their metabolism, and aggregation of PrP
C to the
PrP
Sc form is likely to alter their homeostasis in affected brains
[13–20]. In support of this hypothesis, scrapie infected hamster
brains show increased imbalance of iron homeostasis with disease
progression, and prion disease affected human and mouse brains
accumulate Fe
2+ and Fe
3+ ions, some in association with PrP
Sc
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aggregation of PrP
C to a PrP
Sc-like form that co-aggregates with
the iron storage protein ferritin, partly explaining the underlying
cause of iron imbalance in diseased brains [25].
To understand the relationship between redox-iron, PrP
C,
PrP
Sc, and associated cytotoxicity, we used cells expressing PrP
C
and mutant forms of PrP as models. Comparison with an
alternative source of free radicals such as H2O2 provided
additional information on the underlying mechanism of toxicity
by free radicals. We chose this approach since familial prion
disorders are likely to provide important mechanistic insight into
the more common but difficult to model sporadic disorders.
Moreover, cell models offer the simplicity, sensitivity, and
specificity of read out that is often difficult to achieve in the
complex milieu of the brain. Where possible, parallels are drawn
with scrapie infected cell lines, hamster brains, and sCJD affected
human brain tissue to validate the results from cell models. We
report that PrP functions as a sink for redox-iron induced free
radicals but not H2O2 by undergoing aggregation, thereby
protecting cells from toxicity. Mutations in PrP influence redox-
iron induced PrP aggregation and cytotoxicity differentially,
providing information on the role of PrP in this process. In
addition, autophagy and astrocyte mediated phagocytosis reduce
redox-iron induced toxicity, demonstrating the complexity of
different biochemical processes and cell types in determining prion
disease associated neuronal degeneration.
Results
Exogenous redox-iron induces aggregation of PrP
C and
selective mutant PrP forms
Exposure of PrP
C-expressing human neuroblastoma cells to a
source of redox-iron induces co-aggregation of PrP
C and cellular
ferritin within lysosomes [25]. To evaluate whether mutations
Figure 1. Exogenous redox-iron induces aggregation of PrP
C and certain mutant PrP forms. (A and B) Control and FAC exposed lysates
from PrP
C, PrP
105L, PrP
102L, PrP
D51-89, and PrP
D23-89 cells were subjected to differential centrifugation, and fractionated proteins were probed for PrP
and ferritin. A significant amount of PrP
C and PrP
105L partition in the detergent insoluble P1 and P2 fractions following exposure to FAC (panel A,
lanes 1–4 vs. 5–8 and lanes 9–12 vs. 13–16), while PrP
102L partitions mainly in the detergent soluble S1 and S2 fractions (panel A, lanes 17–24), and
PrP
D51-89 and PrP
D23-89 partition equally between soluble (S1, S2) and insoluble (P1, P2) fractions (panel B, lanes 1–16) in the absence or presence of
FAC.
doi:10.1371/journal.pone.0011420.g001
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neuroblastoma cells expressing PrP
C and mutant forms PrP
P105L
or PrP
P102L that segregate with GSS, and PrP
D51-89 or PrP
D23-89
lacking the copper binding octa-peptide repeat sequence or N-
terminal 90 amino acids respectively were exposed to 0.1 mM
ferric ammonium citrate (FAC) or PBS for 48 hours and subjected
to differential centrifugation to identify aggregated PrP forms. This
procedure involves centrifugation of lysates at 290 g to isolate low
speed detergent soluble supernatant (S1) and insoluble pellet
fractions (P1), followed by ultra-centrifugation of S1 at 100,000 g
to separate high speed detergent soluble (S2) and insoluble (P2)
fractions. Under normal conditions, majority of PrP
C and ferritin
fractionate in the detergent soluble S1 and S2 fractions. Only
minimal amounts are detected in the high speed pellet fraction P2.
As expected, PrP
C from control cells is detected in S1 and S2
fractions (Figure 1 A, lanes 1 and 3). Minimal amounts partition in
the low and high speed pellet fractions P1 and P2 (Figure 1 A,
lanes 2 and 4). Following a 48 hours exposure to FAC, PrP
C is up
regulated (Figure 1 A, lane 1 vs. 5), and a significant amount
partitions in the detergent insoluble P1 and P2 fractions (Figure 1
A, lanes 6 and 8) [25]. A similar evaluation of PrP
P105L-cells
reveals mostly detergent soluble forms of PrP
105L in control cells
(Figure 1 A, lanes 9 and 11). Exposure to FAC causes up
regulation as observed for PrP
C (Figure 1 A, lane 9 vs. 13), and re-
distribution of PrP
105L to detergent insoluble fractions P1 and P2
(Figure 1 A, lanes 14 and 16). PrP
P102L is also up regulated in
response to FAC (Figure 1 A, lane 17 vs. 21), but unlike PrP
C and
PrP
P105L, partitions entirely in the detergent soluble S1 and S2
fractions regardless of exposure to FAC (Figure 1 A, lanes 21–24).
PrP
D51-89 and PrP
D23-89 are not up regulated by FAC (Figure 1 B,
lanes 1 vs. 5 and 9 vs. 13), and partition equally between detergent
soluble and insoluble fractions in the absence or presence of FAC
(Figure 1 B, lanes 1–16).
Re-probing for ferritin shows significant up regulation following
exposure to FAC, and variable distribution between detergent soluble
and insoluble fractions in the cell lines tested (Figures 1 A and B). The
only exception is cells expressing PrP
P102L, where ferritin partitions
exclusively in S1 and S2 fractions (Figure 1 A, lanes 17, 19, 21 and
23). Staining of PVDF membranes with Ponceu-S for all protein
bands shows that the observed differences in PrP distribution are not
an artifact of protein loading (Figure S1 A and S1 B).
To evaluate whether PrP and ferritin form a complex, PrP
C,
PrP
105L, PrP
102L, PrP
D23–89, and PrP
145stop-cells were exposed to
0, 0.05 and 0.1 mM of FAC for 48 hours, and clarified lysates
were immunoprecipitated with either anti-PrP (8H4) or anti-
ferritin antibody followed by immunoblotting of eluted proteins
with a different anti-PrP antibody 3F4. Eluates from all cell lines
show the expected glycoforms of PrP in 8H4 immunoprecipitates
(IP) except the PrP
145stop sample that lacks the epitope for 8H4
(Figure 2 A, lanes 1–3, 7–9, 13–15, 19–21, and 25–27).
Immunoprecipitation with anti-ferritin antibody, on the other
hand, co-precipitates unglycosylated form of PrP
C (lanes 4–6),
unglycosylated and diglycosylated forms of PrP
105L (lanes 10–12),
barely detectable unglycosylated PrP
102L (lanes 16–18), unglyco-
sylated PrP
D23–89 (lanes 22–24), and no PrP
145stop (lanes 28–30).
The amount of PrP co-precipitating with anti-ferritin appears to
increase on exposure of cells to FAC, though it is difficult to draw
quantitative comparisons from IP results. The observed results are
not due to non-specific binding of PrP or ferritin to beads or
antibody since no protein bands are detected in the PrP
145stop
sample (Figure 2 A, lanes 25–30). Together, these observations
suggest that PrP and ferritin form a complex, especially after
exposure to FAC.
PrP co-aggregates with ferritin in lysosomes and
autophagosomes
Relevance of the above observations to prion disease patho-
genesis was assessed by performing a similar analysis on scrapie
infected cell lines ScN2a and SMB. Exposure of cells to 0.1 mM
FAC for 24 hours followed by immunostaining for PrP using 8H4-
Figure 2. PrP and ferritin co-immunoprecipitate in FAC treated cells. Cell lysates prepared from PrP
C, PrP
105L, PrP
102L, PrP
D23–89, and
PrP
145stop-cells exposed to the indicated concentrations of FAC were immunoprecipitated with either anti-PrP antibody 8H4 or anti-ferritin antibody,
and eluted proteins were immunoblotted with anti-PrP antibody 3F4. Immunoblotting of 8H4 immunoprecipitates reveals the expected glycoforms
of PrP for all cell lines as expected (lanes 1–3, 7–9, 13–15, 19–21, and 25–27). Antibody to ferritin co-immunoprecipitates unglycosylated form of PrP
C
(lanes 4–6), unglycosylated and diglycosylated forms of PrP
105L (lanes 10–12), minimal amounts of unglycosylated PrP
102L (lanes 16–18),
unglycosylated PrP
D23–89 (lanes 22–24), and no PrP forms from PrP
145stop-cells (lanes 28–30). Co-immunoprecipitated PrP forms increase with
increasing concentration of FAC (lanes 4 vs. 6, 10 vs. 12, and 22 vs. 24). A small amount of PrP
C co-immunoprecipitates with ferritin even in the
absence of FAC (lane 4).
doi:10.1371/journal.pone.0011420.g002
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(red) shows co-immunostaining of PrP and ferritin in vesicular
structures consistent with lysosomes (Figure 3 A, panels 1–3,
arrow-heads). Exposure to FAC increases the expression and co-
localization of PrP and ferritin significantly in both cell lines as
noted in Figure 1 A above and previous reports (Figure 3 A, panels
4–9, arrow-heads) [25,26].
The cellular compartment(s) of ferritin accumulation was
further characterized by processing FAC exposed PrP
C-cells for
electron microscopy (EM) to visualize iron rich and thereby
electron-dense ferritin aggregates. Dark granular deposits of iron
are clearly visible in single-membrane enclosed lysosomes
containing lamellar structures and cell debris (Figure 3 B, arrow-
heads). Control cells cultured in normal medium do not show
similar deposits (data not shown).
To evaluate whether these compartments represent autophago-
somes, lysates prepared from control and FAC exposed cells and
brain homogenates from sCJD and age-matched controls were
immunoblotted for LC3-I and II (Figure 4 A, lanes 1–4) [27–29].
FAC treated lysates show an increase in LC3-II by 3.7 fold relative
to untreated controls (Figure 4 B), and sCJD homogenates show a
1.8 fold increase compared to age-matched controls (Figure 4 C).
A similar analysis of scrapie infected hamster brains shows higher
levels of LC3-II at 12 weeks post-inoculation (pi) relative to
matched controls (Figure 5 A, lanes 7–9 vs. 13–15). Furthermore,
LC3-II levels increase as the disease progresses from 6 to 12 weeks
pi (Figure 5 A, lanes 1–9), while matched controls show minimal
change (Figure 5 A, lanes 10–15). Quantitative estimation of LC3-
II vs. LC3-I after normalization with b-actin shows an increase of
1.6 and 2.2 fold at 9 and 12 weeks pi relative to 12 week controls
Figure 3. PrP-ferritin aggregates accumulate lysosomes and autophagosomes. (A) ScN2a and SMB cells cultured in the presence of 0.1 mM
FAC or vehicle were permeabilized and immunoreacted with PrP specific mouse monoclonal 8H4 followed by anti-mouse FITC, and polyclonal anti-
ferritin followed by anti-rabbit-TRITC antibodies. FAC exposed cells show prominent aggregates of PrP and ferritin in membrane-enclosed structures
(panels 4–9). Control cells also show similar aggregates, but the amount is several-fold less than treated cells (panels 1–3). Bar: 10 mm. (B) Electron-
microscopy of FAC exposed PrP
C-cells shows electron-dense iron deposits in structures consistent with lysosomes and/or autophagosomes. Bar:
1 mm.
doi:10.1371/journal.pone.0011420.g003
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pi relative to 6 weeks pi (Figure 5 B). These observations indicate
up regulation of autophagy on exposure of cells to FAC, in sCJD
brains, and in scrapie infected hamster brains with disease
progression.
PrP modulates iron induced cytotoxicity
The role of PrP
C in redox-iron induced toxicity was evaluated
by exposing M17 cells expressing low levels of PrP or transfected
to express 6–10 fold higher levels of PrP
C and mutant PrP forms to
FAC (Figures 6–8 and Table 1). Exposure to 0.05 or 0.1 mM FAC
for 6 hours followed by DNA fragmentation assay shows higher
sensitivity of M17 relative to PrP
C-cells (Figure 6 A, lanes 3 and 6).
Evaluation of cell viability at different time points following
exposure to FAC shows relatively less cytotoxicity in PrP
C-cells
after 6 and 16 hours, and a surprising 50% increase after 48 hours
of exposure relative to M17 cells (Figure 6 B). Control M17 and
PrP
C cells cultured in the absence of FAC show minimal
differences in viability for up to 48 hours (Figure 6 B). A similar
evaluation of mutant cells lines with PrP
C-cells shows an increase
in cytotoxicity by 37, 69, and 51% in PrP
102L-cells, and 29, 100,
and 55% in PrP
D51–89-cells after 6, 16, and 48 hours of exposure
respectively (Figure 6 C). Surprisingly, PrP
217R cells show higher
number of dead cells at 6 and 16 hours, and a decrease by 23%
relative to PrP
C-cells after 48 hours of exposure (Figure 6 C).
Control PrP
C and mutant cell lines show minimal cytotoxicity at
all time points tested (Figure 6 C). Thus, PrP
C-cells show relative
resistance to FAC at early time points, and an exponential increase
in cell death at later times. Mutant cell lines PrP
102L and PrP
D51–89
show higher sensitivity relative to PrP
C-cells at all time points,
while PrP
217R-cells show increased sensitivity at early time points
and relative resistance after 48 hours of exposure (Figure 6 C).
To evaluate the relationship between PrP aggregation and
redox-iron induced toxicity, cells expressing PrP
C that aggregates,
and PrP
102L that does not aggregate in response to FAC were
exposed to 0.1 mM FAC for 48 hours, and levels of reactive
oxygen species (ROS) and markers of cell death were compared
(Figure 7 A–D). Immunofluorescence staining shows intracellular
aggregates of PrP
C and minimal aggregation of PrP
102L under
these conditions (Figure 7 A, panels 2 and 4). Estimation of
cytotoxicity by Annexin V and TUNEL staining shows increased
death in PrP
102L-cells relative to similarly treated PrP
C-cells
(Figure 7 B, panel 4 vs. 1–3, and Figure 7 C, panel 2 vs. 1). In
addition, PrP
102L-cells show increased reaction for ROS when
exposed to FAC (Figure 7 D, panel 4 vs. panels 1–3), suggesting
impaired ability to quench FAC induced free radicals.
Figure 4. Autophagy is up regulated in FAC exposed cells and
sCJD brains. (A) Control and FAC exposed PrP
C cell lysates and brain
homogenates prepared from sCJD and age-matched controls were
analyzed by Western blotting and probed with anti-LC3 antibody and
re-probed for b-actin. FAC exposed lysates and sCJD samples show
higher levels of LC3-II relative to controls (lanes 1 vs. 2 and 3 vs. 4). (B
and C) Quantitative estimation shows significant increase in LC3-II vs.
LC3-I in FAC treated lysates and sCJD samples relative to matched
controls.
doi:10.1371/journal.pone.0011420.g004
Figure 5. Autophagosomes increase with prion disease pro-
gression. (A) Immunoblotting of scrapie infected hamster brains with
LC3 antibody shows increase in LC3-II levels with disease progression
relative to age-matched controls (lanes 1–9 vs. 10–15). (B) Quantitative
estimation after normalization with b-actin shows significant increase in
LC3-II relative to LC3-I in diseased samples 9 and 12 weeks post-
inoculation relative to matched controls. *p,0.001; **p,0.01 as
compared to NHa. In addition, diseased samples show a significant
increase in LC3-II in 9 and 12 weeks post-inoculation samples relative to
the 6 week sample.
$p,0.001 relative to ScHa at 6 weeks.
doi:10.1371/journal.pone.0011420.g005
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FAC for 48 hours shows maximal cytotoxicity in cells expressing
non-aggregating mutant PrP forms (PrP
D51–89, PrP
D23–89, PrP
102L),
followed in decreasing order by aggregating mutant PrP forms
(PrP
187R, PrP
188T, PrP
203I, PrP
212P, PrP
200K), aggregating normal
PrP
C and certain mutant PrP forms (PrP
196K, PrP
117V, PrP
211Q,
PrP
188T, PrP
105L), and the least in non-transfected M17 and cells
expressing secreted PrP
C forms (PrP
231stop, PrP
217stop) (Table 1).
Cells expressing PrP
217R are an exception since these are relatively
resistant to FAC despite their tendency to aggregate [30]. The
difference in cytotoxicity between different cell lines does not
correlate with PrP expression levels (Figure 8 A and B).
FAC induced toxicity is mitigated by astrocytes
Since scrapie infected cell lines ScN2a and SMB respond in a
similar fashion to FAC as PrP
C-cells [26], the relationship between
PrP
Sc-ferritin aggregates and cytotoxicity was evaluated as above.
Thus, SMB cells were exposed to FAC for 24 hours, the time point
at which PrP
C-cells show an exponential increase in toxicity
(Figure 3 B), and cell viability was assessed. Compared to
untreated controls, exposure to FAC increases the number of
dead cells from 2 to 55% (Figure 9). Surprisingly, co-culture with
an astrocytoma cell line SW1088 (SW) decreases the number of
dead cells to 20%, demonstrating a protective effect either by
direct contact or through secretion of anti-oxidants (Figure 9).
To differentiate between these possibilities, SMB cells were co-
cultured with SW cells in the presence of FAC for 24 hours and
immunostained for PrP and ferritin. Cell viability was assessed by
counting condensed nuclear chromatin stained with Hoechst
(Figure 10 A, panels 1 and 2). SMB cells (*) are distinguishable
from SW cells (@) that stain minimally for PrP (green), robustly for
ferritin (red), and contain large, open nuclei (Figure 10 B, panels
1–4). FAC exposed SMB cells show prominent intracellular
aggregates that co-immunostain for PrP (green) and ferritin (red)
(Figure 10 B, panels 1–4, arrow-heads). Several of these aggregates
appear to have undergone phagocytosis by adjacent SW cells
(Figure 10 B, panels 1–4, arrows). Neither cell line shows signs of
toxicity despite the presence of intracellular PrP-ferritin aggregates
(Figure 10 B, panels 1–4). Similar evaluation of SMB cells in the
absence of astrocytes (Figure 10 A, panel 1) or in the presence of
astrocyte CM shows significant toxicity by FAC (data not shown).
These observations indicate that PrP-ferritin aggregates are toxic,
and elimination of these complexes by SW cells improves cell
viability despite the presence of FAC.
A similar evaluation was carried out on neuroblastoma cells
expressing normal and mutant PrP forms to ascertain the
Figure 6. PrP modulates FAC induced cytotoxicity. (A) M17 and PrP
C-cells were exposed to indicated concentrations of FAC and extracted DNA
was visualized. Exposure to 0.1 mM FAC causes fragmentation of DNA from M17 cells and minimal change in the PrP
C sample (lanes 3 vs. 6). (B)
Quantification of FAC induced toxicity at the indicated times shows significant resistance of PrP
C-cells after 6 and 16 hours, and an exponential
increase after 48 hours relative to M17 cells. *p,0.001; **p,0.01 as compared to untreated controls;
#p,0.001 as compared to 16 hour FAC treated
PrP
C cells. (C) Comparison of mutant cell lines with PrP
C-cells shows significantly higher toxicity of PrP
102L and PrP
D51–89-cells at 16 hours and
48 hours relative to PrP
C-cells. PrP
217R-cells show increased toxicity after 16 hours followed by a decline in cell death after 48 hours. *p,0.001;
**p,0.01 as compared to untreated controls;
#p,0.001 as compared to 48 hour FAC treated PrP
C cells.
doi:10.1371/journal.pone.0011420.g006
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C and mutant cell
lines PrP
D51–89, PrP
P102L, and PrP
217R were cultured under four
different conditions: 1) normal medium (controls), 2) medium
supplemented with 0.1 mM FAC, 3) 1:1 mixture of fresh and SW-
CM supplemented with 0.1 mM FAC, and 4) 1:1 mixture of a
specific cell line and SW cells in medium supplemented with
0.1 mM FAC. Cells were cultured for 48 hours, and viability was
assessed by counting Hoechst stained condensed nuclear chroma-
tin. As noted for SMB cells, FAC induces significant toxicity in all
cell lines tested. Addition of CM does not alter cell viability,
whereas co-culture with SW cells reduces cell death significantly.
Quantitative comparison shows that co-culture with SW cells
decreases FAC induced toxicity by 74%, 72%, 51%, 57% and
46% in M17, PrP
C, PrP
D51–89, PrP
P102L, and PrP
217R -cells
respectively (Figure 11 A).
Exposure of the same cell lines to H2O2, another source of free
radicals, shows different results. All cell lines are very sensitive to
0.3 mM H2O2 for 6 hours, reaching near 100% cell death. Co-
culture with SW cells has no protective effect, whereas culture in
astrocyte CM decreases H2O2 induced toxicity by 70%, 69%,
51%, 68% and 64% in M17, PrP
C, PrP
D51–89, PrP
P102L, and
PrP
217R-cells respectively (Figure 11 B). Together, the above
results demonstrate that FAC induced toxicity is mediated by
intracellular PrP-ferritin aggregates, while H2O2 induces toxicity
through extracellular free radicals.
Discussion
This report elucidates possible mechanism(s) underlying iron
mediated neurotoxicity in prion disorders, and clarifies the role of
PrP and astrocytes in this process. Using cell models of familial
prion disorders, we demonstrate that aggregation of PrP
C and
certain mutant forms of PrP in response to redox-iron protects
cells from iron-induced acute toxicity. However, subsequent co-
aggregation of PrP with ferritin renders these aggregates redox-
active, resulting in an exponential increase in cytotoxicity at later
time points. Mutant PrP forms that do not aggregate under similar
conditions are not protective, leading to acute cell death. In
addition, astrocyte mediated phagocytosis and perhaps autophagy
of PrP-ferritin aggregates protects cells against toxicity, highlight-
Figure 7. Aggregation of PrP is cytoprotective. (A) Immunoreaction with 8H4 shows intracellular aggregates of PrP
C following exposure to FAC
(panel 2), and minimal aggregation of PrP
102L under similar conditions (panel 4). Bar: 10 mm. (B) Reaction with Annexin V shows minimal effect of FAC
on PrP
C-cells (panels 1 and 2), while PrP
102L-cells show increased reaction (panels 3 and 4). Bar: 10 mm. (C) FAC exposure increases the number of
TUNEL positive PrP
102L-cells significantly relative to PrP
C-cells (panels 1 and 2). Bar: 10 mm. (D) PrP
102L-cells show significantly more reaction for ROS
after exposure to FAC compared to similarly treated PrP
C-cells (compare panels 2 and 4). Bar: 10 mm.
doi:10.1371/journal.pone.0011420.g007
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neuronal survival. Mouse scrapie infected cell lines and prion
disease affected hamster and human brains show similar results,
demonstrating the relevance of these findings to prion disease
associated neurotoxicity.
Redox-iron has emerged as an important cause of neurotoxicity
in several neurodegenerative conditions in addition to prion
disorders, including Alzheimer’s disease, Parkinson’s disease,
Huntington’s disease, Friedreich’s ataxia, multiple sclerosis, Pick’s
disease, Hallervorden-Spatz disease, tardive dyskinesia, acerulo-
plasminemia, and others [31–37]. In each of these disorders, a
redox-active metal such as iron is reduced in the presence of a
specific protein, resulting in the generation of free radicals and
consequent aggregation of the protein [36,38–40]. The patho-
physiology of prion disorders renders affected brains especially
prone to metal dyshomeostasis since PrP
C is involved in the uptake
and transport of iron and copper [18,20,26], and aggregation to
the PrP
Sc form is likely to alter copper and iron homeostasis due to
the combined effect of loss of PrP
C function and sequestration of
these metals by PrP
Sc, rendering the aggregates redox-active. A
specific example of this phenomenon has been reported in a cell
model, demonstrating the sensitivity of PrP
C to excess redox-iron
[25]. However, the molecular mechanism(s) underlying redox-iron
mediated neurotoxicity and its role in the pathogenesis of familial
prion disorders has not been explored.
Our results show that cells expressing normal and mutant forms
of PrP elicit a distinct response when exposed to a source of redox-
iron such as FAC. M17 cells that over-express PrP
C show
resistance to higher amounts of FAC relative to non-transfected
cells, suggesting a dose-dependent protection against redox-iron.
Surprisingly, PrP
C-cells show significantly higher toxicity relative
to M17 cells after the first 16 hours of exposure even if FAC is
removed from the medium (unpublished observations). One likely
explanation for these observations is that interaction of redox-iron
with copper and iron bound PrP initiates the Fenton reaction,
resulting in denaturation and aggregation of PrP at the cell surface
Figure 8. Cytoprotective effect of PrP is independent of its expression level. (A) Equal amount of protein from lysates of M17, PrP
C, PrP
102L,
PrP
105L, PrP
196K, PrP
200K, PrP
203I, PrP
212P, PrP
211Q, PrP
D23–89, PrP
187R, PrP
188T, PrP
231stop, PrP
217R, PrP
117V, and PrP
D51–89 was subjected to Western
blotting. Probing for PrP shows the expected glycoforms of PrP in all cell lines (lanes 1–16). Re-probing for b-actin shows equal loading of protein. (B)
Quantification after normalization with b-actin shows 6–10 fold higher expression of PrP
C and mutant cell lines relative to M17 cells. The only
exception are PrP
231stop-cells that express 1.8 fold higher levels of PrP
C compared to M17 cells. Quantitative analysis of one representative experiment
is shown.
doi:10.1371/journal.pone.0011420.g008
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aggregation of PrP provides protection against redox-iron induced
toxicity. However, subsequent transport of PrP aggregates to
lysosomes and association with ferritin results in the formation of a
complex that is resistant to degradation by proteases and is itself
redox-active [25, this report], causing an exponential increase in
cell death. Since M17 cells express lower levels of PrP
C, a similar
paradoxical response to redox-iron does not occur. Morphological
evaluation of FAC exposed PrP
C cells confirms the accumulation
of PrP-ferritin complexes in lysosomes, and EM analysis indicates
that aggregated ferritin is rich in iron, some of which precipitates
out and is visible as electron dense granules. It is likely that the
iron-rich nature of these aggregates combined with resistance to
proteolytic digestion is responsible for the late toxicity in PrP
C
cells.
Cells expressing mutant PrP forms show significantly higher
toxicity to FAC than PrP
C-cells at all time points tested. Since
several of the mutant PrP forms aggregate with similar kinetics
as PrP
C, it is likely that mutant PrP is inefficient in sequestering
free radicals at the cell surface and intracellularly, resulting in
direct damage from exogenous redox-iron and from intra-
cellular redox-active mutant PrP-ferritin aggregates. Certain
fragments of mutant PrP forms generate significantly higher
levels of free radicals when exposed to copper, supporting this
claim [39,44–46]. It is surprising to note that cells expressing
PrP
217R show higher toxicity than PrP
C cells in the first
16 hours, followed by a drop in cell death after 48 hours. It is
likely that PrP
217R aggregates are not effective in quenching free
radicals on the cell surface, but form fairly stable intracellular
aggregates with ferritin that are less redox-active than PrP
C-
ferritin, thereby alleviating late toxicity. Cells expressing
anchor-less PrP forms such as PrP
231stop and PrP
217stop show
similar toxicity as M17-cells, indicating that expression of PrP
on the plasma membrane is necessary for protection, and intra-
cellular aggregation of PrP-ferritin complexes is essential for late
toxicity. Cells expressing other mutations such as PrP
102L,
PrP
D23–89,a n dP r P
D51–89 that do not aggregate in the presence
of FAC show increased levels of intracellular ROS and toxicity
a ta l lt i m ep o i n t st e s t e d .T h ee x t e n to fc e l ld e a t hi nt h e s ec e l l si s
significantly higher at all time points than PrP
C and mutant cell
lines that aggregate in response to FAC, supporting the
protective role of PrP aggregation against acute toxicity. Scrapie
infected cell lines show significantly higher toxicity to FAC such
that ten times lower levels are sufficient to cause apoptosis
(unpublished observations). Increased sensitivity of these cells to
FAC may be due to lower expression of PrP
C on the cell surface
combined with relatively rapid accumulation of PrP
Sc-ferritin
aggregates on pre-existing PrP
Sc seed.
It is surprising that PrP
102L and PrP
105L that segregate with GSS
respond differently to FAC despite their physical proximity within
the protein sequence and similar amino acid mutations. Although
information on the copper and iron binding capacity of PrP
102L
and PrP
105L is not available, it is known that PrP
102L shows
delayed recycling to the plasma membrane [47], a defect that may
be responsible for increased accumulation of iron in cellular
ferritin in PrP
102L cells and a paradoxical phenotype of iron
deficiency [19]. Perhaps internalized PrP
102L forms a complex
with ferritin that interferes with its transport back to the plasma
membrane, accounting for the lack of free radical quenching
activity of PrP
102L on the cell surface, absence of PrP
102L
aggregates, increased levels of intracellular ROS, and increased
susceptibility to FAC. Failure of PrP
D23–89 and PrP
D51–89 to
aggregate is perhaps due to decreased iron and/or copper binding,
compromising their ability to protect cells against FAC induced
injury.
All the cell lines tested except PrP
102L show up regulation and
aggregation of ferritin in response to FAC. Immunofluorescence
Table 1. Correlation between FAC induced PrP and ferritin
aggregation and cytotoxicity.
Cell line
PrP
aggregation
Ferritin
aggregation
Condensed
chromatin (%)
M17 2/++ 1861
PrP
C ++ *3162
Pathogenic mutations
PrP
105L ++ 3562
PrP
102L 22 /+
#4463
PrP
187R ++
#3862
PrP
188T ++ 3562
PrP
203I ++
#3961
PrP
211Q ++ 3662
PrP
212P ++
#3862
PrP
217R ++
#1961
PrP
117V ++ 3561
PrP
200K ++
#3862
PrP
196K ++ 3662
Non-pathogenic mutations
PrP
D51–89 2 +
#4362
PrP
D23–89 2 +
#4563
PrP
231stop 2 +
#2062
PrP
217stop 2/++
#1961
FAC: 0.1 mM for 48 hours.
n=6 independent evaluations for all cell lines. M17 vs. PrP
C:
*p,0.001; PrP
C vs. mutant cell lines:
#p,0.001.
doi:10.1371/journal.pone.0011420.t001
Figure 9. FAC induced toxicity is mitigated by astrocytes.
Exposure of SMB cells to FAC causes a significant increase in toxicity
that is reduced by co-culture with SW cells. *p,0.001 as compared to
untreated SMB cells;
#p,0.001 relative to FAC treated SMB cells.
doi:10.1371/journal.pone.0011420.g009
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structures in association with aggregated PrP, and EM analysis of
FAC exposed PrP
C cells reveals accumulation of electron-dense,
iron-rich aggregates in structures consistent with lysosomes/
autophagosomes. Biochemical analysis of FAC exposed PrP
C cells
confirms this observation by demonstrating up regulation of LC3-
II, a marker of autophagy [27–29]. A similar increase in LC3-II
levels is observed in scrapie infected hamster and sCJD affected
human brains, demonstrating the occurrence of similar processes
in prion disease affected brains. In hamster samples, levels of LC3-
II increase with disease progression, suggesting an increase in
autophagosome activity with disease progression. Whether this
phenomenon occurs due to accumulation of PrP
Sc-ferritin
complexes is unclear from our data, but is a likely possibility
[19,28].
Our observations on FAC exposed scrapie-infected cell lines
show that co-culture with astrocytoma cells induces active
phagocytosis of PrP
Sc-ferritin complexes and rescues cells from
toxicity. Culture in astrocyte conditioned medium is not
protective, suggesting that protection is derived from clearance
Figure 10. PrP-ferritin aggregates are phagocytosed by astrocytes. (A) SMB cells (panel 1) or co-cultures of SMB and SW cells (panel 2) were
exposed to the indicated amount of FAC and immunostained for PrP (green), ferritin (red), and nuclear dye Hoechst (blue). Punctate staining of PrP is
noted intracellularly and in cellular processes of SMB cells (panels 1 and 2, green). SW cells are larger in size, show minimal reactivity for PrP, and
contain large nuclei with open chromatin (panel 2), allowing distinction from SMB cells. Bar: 10 mm. (B) Higher magnification of boxed areas from
panel 2 shows reactivity for PrP within SMB cells and their processes (panels 1 and2, (*)). SW cells show minimal staining for PrP, increased reactivity
for ferritin, and large nuclei with open chromatin (panels 3 and 4, (@)). Aggregates of PrP in SMB cells co-immunostain for ferritin (panels 1–4, arrow-
heads), suggesting co-aggregation of PrP and ferritin. Aggregates of PrP and ferritin are detected on the cell surface and cytosol of SW cells,
indicating phagocytosis by the latter (panels 1–4, arrows). (Only prominent groups of aggregates are marked for clarity). Bar: 10 mm.
doi:10.1371/journal.pone.0011420.g010
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in the extra-cellular milieu. This assumption is supported by the
fact that co-culture of FAC exposed scrapie infected cells or cell
lines expressing normal and mutant PrP forms does not protect
cells from H2O2 induced toxicity, whereas culture in astrocyte CM
reduces toxicity by H2O2 significantly. These observations suggest
that PrP-ferritin aggregates are intrinsically toxic, perhaps due to
their redox-active nature. Although extracellular FAC could
induce toxicity due to free radicals independent of PrP-ferritin
aggregates, the concentrations of FAC used in our experimental
paradigm are non-toxic for at least 48 hours, suggesting that
toxicity is mainly through intracellular events. It is likely that
within the brain astrocytes protect scrapie infected neurons by
phagocytosing PrP
Sc aggregates, thereby reducing free radicals in
the intra- and extra-cellular milieu.
In conclusion, this report highlights the paradoxical role of PrP
in redox-iron induced toxicity, and escalation of the toxic signal by
mutant PrP forms. Since chelation of iron from diseased brain
homogenates reduces the redox-activity and protease-resistance of
PrP
Sc complexes [25], it is possible that restoration of iron
homeostasis in diseased brains would decrease or eliminate both
extra-cellular toxicity by redox-iron and intracellular toxicity by
redox-active PrP
Sc-ferritin complexes. Although encouraging,
restoration of iron homeostasis in diseased brains is a daunting
task due to the complexity of biochemical pathways and cellular
interactions responsible for this process. The protective effect of
phagocytosis is encouraging, but further investigations are
necessary to fully understand and exploit this pathway.
Materials and Methods
Materials and antibodies
Primary antibodies 3F4 and 8H4 against PrP were purchased
from Signet Laboratories (Dedham, MA) and provided by Drs.
Pierluigi Gambetti and Man Sun-Sy (National Prion Surveillance
Center, Case Western Reserve University). LC3 antibody was
obtained from Cell Signaling Technology (Cat. No. 2775).
Polyclonal anti-ferritin antibody was procured from Sigma-Aldrich
(St. Louis, MO, Cat. No. F5012), horseradish peroxidase (HRP)-
labeled secondary antibodies were from GE Healthcare (Little
Chalfont, Buckinghamshire, United Kingdom), FITC (fluorescein
isothiocyanate) and TRITC (tetramethylrhodamine B isothiocya-
nate) labeled secondary antibodies were from Southern Biotech-
nology Associates (Brimingham, AL). Hoechst was obtained from
Invitrogen (Cat. No. H3570), and Hygromycin was procured from
Calbiochem (San Diego, CA, Cat. No. 400051). All other reagents
including Ferric Ammonium Citrate (FAC) were obtained from
Sigma-Aldrich, unless otherwise mentioned.
Cell culture
Human neuroblastoma cells (M17) over expressing PrP
C or
mutant PrP forms were generated and cultured as described earlier
[30]. Additional point mutations were generated for this study using
the QuickChange XL Site-Directed Mutagenesis Kit (Agilent
Technologies, La Jolla, CA 92037, Cat. No. 200517) and maintained
in the presence of hygromycin as described previously [48]. Scrapie-
infected mouse neuroblastoma cells (ScN2a) and SMB cells were
obtained from Dr. Byron Caughey (Rocky Mountain Laboratories)
and Dr. Glenn Telling (University of Kentucky) respectively, and
maintained in Medium 199 supplemented with 10% Normal Calf
Serum (NCS), and 1% Penicillin-Streptomycin (PS). Human
astrocytoma cell line SW1088 (ATCC No. HTB-12) was obtained
fromAmericanTypeCultureCollection(ATCC,Manassas,VA)and
cultured in high glucose DMEM supplemented with 10% FBS and
1% PS. All cultures were maintained at 37uCi nah u m i d i f i e d
atmosphere containing 5% CO2.
Aggregation assay
Equal numbers of cells expressing PrP
C or a specific mutant PrP
form were cultured in complete medium in the presence of
0.1 mM FAC dissolved in Opti-MEM. Control cultures were
maintained under similar conditions with no added FAC.
Following an incubation of 48 hours, cells were checked for any
signs of toxicity, rinsed with cold PBS, and lysed in a buffer
containing 100 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1% NP-40,
0.5% DOC and 10 mM EDTA. Lysates were subjected to
differential centrifugation to identify aggregated PrP forms as
described in earlier reports [25]. In short, following a low speed
spin at 290 g to isolate low speed supernatant (S1) and pellet
fractions (P1), the S1 fraction was subjected to ultra-centrifugation
at 100,000 g to separate the high speed supernatant (S2) and
aggregated pellet (P2) fractions. Proteins from each fraction were
precipitated with cold methanol, boiled in sample buffer, and
Figure 11. FAC induced toxicity is through PrP-ferritin
aggregates. (A) Quantification of FAC induced cell death in M17,
PrP
C and mutant cell lines PrP
D51–89, PrP
P102L, and PrP
217R when cultured
in the presence of SW CM or co-cultured with SW cells shows significant
toxicity by FAC in all cell lines, minimal protective effect of CM, and
significant rescue by co-culture with SW cells. *p,0.001; **p,0.01 as
compared to untreated controls;
$p,0.001 as compared to FAC and
FAC+CM treated cells. (B) Exposure of the same cell lines to H2O2
induces death in all cell lines as expected, and significant rescue by SW
CM. Co-culture with SW cells has no measurable effect. *p,0.001 as
compared to untreated controls;
#p,0.001 as compared H2O2,
H2O2+SW treated cells.
doi:10.1371/journal.pone.0011420.g011
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probed for PrP and ferritin using specific antibodies.
Western blot analysis
Cell lysates or 10% brain homogenates prepared in lysis buffer
as above were resolved on SDS-PAGE and transferred to a PVDF
membrane. After blocking the membrane with 5% milk in TBST
(20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 0.1% Tween 20),
membranes were washed with TBST and probed with specific
antibodies followed by HRP-conjugated secondary antibodies.
Reactive bands were visualized using ECL detection kit (Amer-
sham Biosciences Inc.).
Immunostaining
ScN2a or SMB cells cultured on poly-L-lysine coated cover slips
were exposed to FAC for 24 hours and processed for immuno-
staining. For co-culture experiments, equal number of SMB and
SW1088 cells were cultured on coverslips, exposed to 0.1 mM
FAC for 24 hours, and processed for immunostaining using PrP
and ferritin specific antibodies as described previously [30].
Co-immunoprecipitation
Cells expressing PrP
C and specific mutant PrP forms cultured as
above were exposed to 0, 0.05, and 0.1 mM FAC for 48 hours and
lysed in a buffer containing 2% Triton X-100 in Tris-buffered
saline (20 mM Tris-HCl, pH 7.4, 150 mM NaCl,) containing
protease inhibitor cocktail. Cell debris was sedimented by
centrifugation at 800 g, and clarified supernatants were rocked
with 4 ml of 8H4 or 2 ml of anti-ferritin antibody in presence of 1%
bovine serum albumin and 0.1% N-lauryl sarcosine. After an
overnight incubation at 4uC, antigen-antibody complexes were
captured with protein A agarose beads (Roche, Cat. No. 1134515)
and washed extensively with wash buffer (150 mM NaCl, 10 mM
Tris-HCl, pH 7.8, 0.1% N-lauryl sarcosine and 0.1 mM phenyl-
methylsulfonyl fluoride). Bound proteins were eluted by boiling in
sample buffer (125 mM Tris-HCl, pH 6.8, 3% SDS, 10% glycerol
and 5% b-mercaptoethanol), resolved by SDS-PAGE, and
subjected to immunoblotting with anti-PrP antibody 3F4.
Electron Microscopy
Cells grown in the presence or absence of 0.1 mM FAC were fixed
in 4% paraformaldehyde in 0.2 M PHEM buffer (120 mM PIPES,
50 mM HEPES, 4 mM MgCl2 and 20 mM EGTA) for 24 h. Fixed
cells were washed twice with PBS+ (PBS containing 0.15 M glycine)
and incubated with 1% gelatin for 30 min at 37uC. After washing
with PBS, cells were stored in storage solution (0.1 M PHEM buffer
containing 4% paraformaldehyde). For electron microscopy, cells
were refixed in PBS containing 2.5% glutaraldehyde, 2% parafor-
maldehyde, and 4% sucrose for 2 hours followed by 1% osmium
tetroxide for 1 hour. After dehydrating in increasing concentrations
of ethanol, cells were embedded in Epon 812 and examined using a
JEOL 1200EX electron microscope.
Toxicity assays
To estimate toxicity of FAC or H2O2, scrapie infected cell lines
ScN2a and SMB or PrP
C and mutant cell lines were exposed to 0,
0.05 or 0.1 mM FAC for 6–48 hours and analyzed for cell death
by DNA fragmentation, LDH release and TUNEL assays, staining
with Annexin-V, and by calculating percentage of Hoechst stained
condensed nuclei in 20 different 40x microscopic fields. For cells
treated with FAC, LDH assay could not be performed as it has
been reported that bipyridyl derivatives of divalent metal ions
inhibit LDH. [49].
For LDH assay, PrP
C and mutant cell lines cultured in 24 well
plates were exposed to different concentrations of H2O2 for the
indicated times, and release of LDH was assessed using the LDH-
cytotoxic assay kit from Wako (cat. No. 299–50601). Based on
these evaluations, optimum concentrations of H2O2 and the time
of exposure were decided. FAC concentration and time of
exposure was decided as reported earlier [25]. DNA fragmentation
assay was carried out on control and FAC exposed cells after
6 hours. In short, cells were rinsed with PBS and lysed in a buffer
containing 10 mM Tris-HCl, pH 7.5, 0.25% NP40, RNAase A
(2 mg/ml), and proteinase-K (2 mg/ml). After incubating the
mixture for 20 minutes at 37uC, lysates were centrifuged at
14,500 rpm for 15 minutes and supernatant was analyzed on 1.5%
agarose gel. DNA ladder was visualized by staining with ethidium
bromide. Tunnel assay was carried out using the In situ Cell Death
detection Kit, TMR red (Roche, Germany). Staining for Annexin
V was performed on cells cultured on poly-L-lysine coated
coverslips using the Annexin V conjugate (Molecular Probes,
Inc., Cat # A13199). TUNEL positive and Annexin V positive
cells were examined under a fluorescence microscope. The level of
ROS produced within control and treated cells was measured by
the cell permeable, non-polar, H2O2-sensitive probe 5,6-chlor-
omethyl-20,70 dichlorodihydro-fluorescein-diacetate (CM-
H2DCFDA) from Sigma, USA. Cells cultured on poly-L Lysine
coated coverslips were exposed to different experimental condi-
tions and treated with 5 mM solution of CM-H2DCFDA at room
temperature for 45 minutes. Cells were then washed with ice-cold
PBS and fluorescence intensity of intracellular DCFDA was
observed under the microscope.
Protection assay
Equal number of SMB and SW1088 cells were seeded to
achieve 70% confluence on poly-L-lysine coated cover slips and
cultured overnight in DMEM supplemented with 10% FBS and
1% PS. Cultures were examined under the microscope to make
sure the cells are making physical contact with adjacent cells. The
medium was removed, and fresh medium supplemented with
0.1 mM FAC was added. After further culture for 24 hours, cells
were rinsed with cold PBS, fixed with paraformaldehyde, and
immunostained for PrP and ferritin as described before [30]. For
cell lines expressing PrP
C and mutant PrP forms, four different
experimental paradigms were tested in the presence of 0.1 mM
FAC for 48 hour and 0.3 mM H2O2 for 6 hours: 1) control
cultures with normal medium, 2) cultures supplemented with FAC
or H2O2, 3) addition of FAC or H2O2 in a 1:1 mixture of fresh
medium and conditioned medium (CM) collected from SW1088
cultures grown to near confluency and clarified by centrifugation,
and 4) co-culture of a 1:1 mixture of the specific cell line and
SW1088 cells. At the end of each incubation, cells were rinsed with
cold PBS, fixed with paraformaldehyde, and nuclei were stained
with Hoechst. Triplicate coverslips from each condition were
examined and the percentage of condensed nuclei was calculated
from 20 different random fields examined under a 40x lens.
Statistical analysis
All experiments were repeated at least three times. The results
are expressed as mean 6 standard error of mean (SEM). Statistical
analysis was done by unpaired Student’s t-test when comparing
two groups. For multiple groups, one way ANOVA followed by
Bonferroni multiple comparison post hoc test was done using
GraphPad Prism software (Version 4.03, GraphPad Inc., San
Diego, CA, USA). Differences were considered significant at
p,0.05.
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Figure S1 Differential fractionation of proteins is not an artifact
of loading. (A & B) PVDF membranes used for probing PrP and
ferritin in Figure 1 were stained with Ponceau S to visualize all
transferred proteins. Comparison of protein loading between
different S1 and S2 fractions and P1 and P2 fractions is similar in
FAC exposed and control samples for all cell lines.
Found at: doi:10.1371/journal.pone.0011420.s001 (1.97 MB TIF)
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